Wednesday, July 8, 2026

pharma · Multiple System Atrophy · ATHE

ALTERITY THERAPEUTICS

ALTERITY THERAPEUTICS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Melbourne, AU HQ
15 Employees
Public company Type
ATHE · NYSE Ticker
Company details
Status
Public
HQ
Melbourne, AU
Employees
15
Programs
3
Drugs
1
Patents
4
Intelligence · Clinical Trials

ALTERITY THERAPEUTICS clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to ALTERITY THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

ALTERITY THERAPEUTICS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for ALTERITY THERAPEUTICS.

  1. ATH434 dose level 1 — Phase 2

    Clinical update
  2. ATH434-DP2 — Phase 2

    Clinical update
  3. ATH434 — Phase 2

    Clinical update

Trial registry

3 studies